All lobbying filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP
BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q3 report for ELI LILLY AND COMPANY on October 16, 2026, reporting $90,000 in lobbying income.
Lobbying for ELI LILLY AND COMPANY · Pharmaceuticals
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Income
$90,000
What the client paid this registrant for the period.
Client based in
Indiana
Lobbyists on this filing
1
-
SARA MORSE New on this filingPreviously held: Principal Deputy Assistant Secretary for Legislation at the Department of Health and Human Services; Deputy Assistant Secretary for Legislation at the Department of Health and Human Services
Government bodies contacted
2
Lobbying activity
2
Issues related to the pharmaceutical industry Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act
Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain